NEW YORK, Aug. 14, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced advances across its Actimab-A program, including recently acquired patents adding to a broad...
Hence then, the article about actinium pharmaceuticals announces actimab a intellectual property and manufacturing advances and provides nyse american listing update was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update )
Also on site :
- ‘The Voice’s Kayleigh Matthews Stuns Coaches With Four-Chair Turn on Vince Gill Cover
- Kylie Jenner Bachelorette Weekend Thriller Getting Hulu Series Order From Kim Kardashian, Lauren Oliver & Kapital Entertainment
- Martha Stewart’s Stylish Stoneware Food Container Set Is Perfect for Leftovers, and Just $25 Ahead of Prime Day